Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination. - Wikidata - wikimedia - TriplyDB

Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination.

Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination.

http://www.wikidata.org/entity/Q42254625

about

3-T MR-guided brachytherapy for gynecologic malignancies.Rapid and accurate T2 mapping from multi-spin-echo data using Bloch-simulation-based reconstruction.Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI Improved T2 mapping accuracy with dual-echo turbo spin echo: effect of phase encoding profile orders.A variable echo-number method for estimating R2 in MRI-based polymer gel dosimetry.Accelerated T2 mapping for characterization of prostate cancer.Detection of alterations in membrane metabolism during neoadjuvant chemotherapy in patients with breast cancer using phosphorus magnetic resonance spectroscopy at 7 Tesla.Characterization of gradient echo signal decays in healthy and cancerous prostate at 3T improves with a Gaussian augmentation of the mono-exponential (GAME) model Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.Optimal configuration for relaxation times estimation in complex spin echo imaging.Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer.Fast T(2) relaxometry with an accelerated multi-echo spin-echo sequence.Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRI sequence Relaxation time estimation from complex magnetic resonance images Immobilized contrast-enhanced MRI: Gadolinium-based long-term MR contrast enhancement of the vein graft vessel wall.Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer.Feasibility of T2 -weighted turbo spin echo imaging of the human prostate at 7 tesla.Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T2 mapping across multiple systems.Repeatability of magnetic resonance fingerprinting T1 and T2 estimates assessed using the ISMRM/NIST MRI system phantom.

P2860

Q30461928-49179A28-05B4-4BA5-B729-163BE6D357D1 Q30781192-EE95C401-0C53-415C-824F-AEF785094DB2 Q30938479-79048C16-208F-4245-ADD2-4E01388D8D99 Q34177953-C4448465-EEFD-41F3-890E-48E577F6611C Q34586419-91EB3B96-9601-49FC-A991-70F8F99C6664 Q34810427-D560D5F2-291B-493E-9FC2-BF6C33A3AF94 Q35537575-C3EEC8B0-9BA9-4500-A20A-021A19F630D0 Q37118580-303CD75D-5857-4EDF-A43C-BD4E94C2F508 Q38100740-4877288E-4532-4024-938E-CA2FD59C2778 Q38333443-7E195CFC-8D8B-49F2-9F95-75C8FBC097DD Q38837797-B45DF95F-08D5-467E-AD43-5E6B72497E7E Q39650157-68683EE5-3E81-484E-AA0D-999F04FABAE6 Q40498085-8B366868-DFCD-4089-9BED-A68FEB8F0C4D Q40911822-9662779E-17FF-471F-8CDB-51652889B1B4 Q41261217-A13D451E-5C9B-4E9C-A393-21B228E7990A Q45119553-91B17EC8-82FF-4A7C-B788-9BD9EDC1ABDD Q45802979-1C2F4E9B-332C-4F5F-ACEF-874C37054106 Q47601675-62E75804-DA33-4945-8938-F744AC477C75 Q47964968-557E9604-7D0E-4FF2-810B-154D160BF73F Q48759561-87F50974-410E-4A94-B5C9-3A9002991AEA

P2860

Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination.

http://www.wikidata.org/entity/Q42254625

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Carr-Purcell-Meiboom-Gill imag ...... ues for cancer discrimination.

@en

Carr-Purcell-Meiboom-Gill imag ...... ues for cancer discrimination.

@nl

type

label

Carr-Purcell-Meiboom-Gill imag ...... ues for cancer discrimination.

@en

Carr-Purcell-Meiboom-Gill imag ...... ues for cancer discrimination.

@nl

prefLabel

Carr-Purcell-Meiboom-Gill imag ...... ues for cancer discrimination.

@en

Carr-Purcell-Meiboom-Gill imag ...... ues for cancer discrimination.

@nl

P1433

Q42254625-20B4DFFB-D703-4911-A708-C7C7B6301B8D

P1476

Q42254625-CEC611CB-CFF7-4941-A223-C6865F15547A

P2093

Q42254625-2D254591-33B0-455E-BC93-E286C5D59733

Q42254625-5004C9D1-12BD-439E-9D40-7E49465ABA27

Q42254625-53528417-BA10-40BE-8FCE-C3B0C1778590

Q42254625-878E81BC-17AA-4FE6-9C43-FBEA344C730C

Q42254625-DDA49DD2-9141-44E6-B8B5-BC469DB6A7E6

Q42254625-E16BAC7B-8949-41A6-B3F6-416849639E04

P2860

Q42254625-001B98D6-5999-4DDC-8922-0F7C3F3CE150

Q42254625-03D6F9AF-3F8F-421E-B3AB-409292E0CDD8

Q42254625-193FB1AD-4E71-44E0-A33C-A175039CE267

Q42254625-1F3B60FF-217D-4488-A3AD-C953C7BBDA11

Q42254625-258F05AD-663A-4FF8-AC93-8A3F7AF94AF4

Q42254625-3464351C-4348-45DD-9C8E-B09E1165D2F1

Q42254625-3E9AD367-49CF-42B4-9F5C-EA104AA93046

Q42254625-3FF0DB4A-6A86-4767-9BA7-E5B8139F07BF

Q42254625-4548C00B-11D5-4625-8393-3C8FBC8C7E2F

Q42254625-5253F9AB-DE0A-4BFA-84BB-130D924A3D1C

P304

Q42254625-9F4D7448-A85E-4EAE-A970-2F8975BDD1C2

P31

Q42254625-8ADB116C-F52D-4784-AD4E-C938291F35CA

P356

Q42254625-B2135523-E2FB-4A8C-B85C-CDAF614689A2

P433

Q42254625-37268FBD-B390-4B14-A3B1-918F2954F3C4

P478

Q42254625-99FEBCC8-FE3C-466A-839E-ADDFB572A2F1

P577

Q42254625-073156A5-AD55-4533-A5CA-0AF7F83776B3

P5875

Q42254625-A37550F2-D5FD-4E03-AC7A-55A2D94D1FB4

P698

Q42254625-921FF98D-87BB-444F-9A61-7FBD84107075

P932

Q42254625-686A9325-3C42-430E-AE6A-BFE0E231097E

P356

J.MRI.2008.08.001

P1433

Magnetic Resonance Imaging

P1476

Carr-Purcell-Meiboom-Gill imag ...... ues for cancer discrimination.

@en

P2093

Clare M Tempany

http://www.w3.org/2001/XMLSchema#string

Dimitris Mitsouras

http://www.w3.org/2001/XMLSchema#string

Frank J Rybicki

http://www.w3.org/2001/XMLSchema#string

Joseph R Roebuck

http://www.w3.org/2001/XMLSchema#string

Robert V Mulkern

http://www.w3.org/2001/XMLSchema#string

Steven J Haker

http://www.w3.org/2001/XMLSchema#string

P2860

Osmotic effects on the T2 relaxation decay of in vivo muscle.

Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.

Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range

Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate.

Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy.

Imaging prostate cancer.

Comparison of conventional single echo and multi-echo sequences with a fast spin-echo sequence for quantitative T2 mapping: application to the prostate.

Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study.

The loss of small objects in variable TE imaging: implications for FSE, RARE, and EPI.

Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.

P304

497-502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MRI.2008.08.001

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23286950

http://www.w3.org/2001/XMLSchema#string

P698

18823731

http://www.w3.org/2001/XMLSchema#string

P932

2720831

http://www.w3.org/2001/XMLSchema#string